Regeneron Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Regeneron Pharmaceuticals patents 704 in total
| Status | Patent |
|---|---|
Application | Utility: RODENTS HAVING GENETICALLY MODIFIED SODIUM CHANNELS AND METHODS OF USE THEREOF Filling date: 12 Sep 2025 Issue date: 27 Aug 2020 |
Grant | Utility: Anti-TIE2 antibodies and uses thereof Filling date: 12 Sep 2025 Issue date: 25 Aug 2020 |
Grant | Utility: Stabilized formulations containing anti-PCSK9 antibodies Filling date: 12 Sep 2025 Issue date: 25 Aug 2020 |
Grant | Utility: Biologically active molecule conjugates, reagents and methods of manufacture, and therapeutic uses Filling date: 12 Sep 2025 Issue date: 25 Aug 2020 |
Grant | Utility: Method for generating high affinity antibodies Filling date: 12 Sep 2025 Issue date: 25 Aug 2020 |
Application | Utility: ANTI-C5 ANTIBODIES AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: ANTI-C5 ANTIBODIES AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: ANTI-IL-25 ANTIBODIES AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: Piezo Type Mechanosensitive Ion Channel Component 1 (PIEZO1) Variants And Uses Thereof Filling date: 12 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: Matrix Extracellular Phosphoglycoprotein (MEPE) Variants And Uses Thereof Filling date: 12 Sep 2025 Issue date: 20 Aug 2020 |
Grant | Utility: Method of treating osteoarthritis with an antibody to NGF Filling date: 12 Sep 2025 Issue date: 18 Aug 2020 |
Application | Utility: CELL CULTURE PROCESS FOR MAKING A GLYCOPROTEIN Filling date: 12 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: Treatment Of Respiratory Disorders With Arachidonate 15-Lipoxygenase (ALOX15) Inhibitors Filling date: 12 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: METHODS FOR TREATING HIGH CARDIOVASCULAR RISK PATIENTS WITH HYPERCHOLESTEROLEMIA Filling date: 12 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: METHOD OF TREATING AN ALLERGY WITH ALLERGEN-SPECIFIC MONOCLONAL ANTIBODIES Filling date: 12 Sep 2025 Issue date: 13 Aug 2020 |
Grant | Utility: Anti-EGFRvIII antibodies and uses thereof Filling date: 12 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: B4GALT1 cDNA variants and compositions comprising the same Filling date: 12 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Human antibodies to PD-1 Filling date: 12 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging Filling date: 12 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Method of averting opioid addiction Filling date: 12 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Bispecific antigen-binding molecules that bind MUC16 and CD3, and compositions thereof Filling date: 12 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Anti-GITR antibodies and uses thereof Filling date: 12 Sep 2025 Issue date: 11 Aug 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR DETECTING A BIOLOGICAL CONTAMINANT Filling date: 12 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR Filling date: 12 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: Native Microfluidic CE-MS Analysis of Antibody Charge Heterogeneity Filling date: 12 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: ANTI-IL2 RECEPTOR GAMMA ANTIGEN-BINDING PROTEINS Filling date: 12 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: METHODS FOR TREATING SEVERE ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR Filling date: 12 Sep 2025 Issue date: 6 Aug 2020 |
Grant | Utility: Anti-CD8 antibodies and uses thereof Filling date: 12 Sep 2025 Issue date: 4 Aug 2020 |
Grant | Utility: Methods for treating eosinophilic esophagitis by administering an IL-4R inhibitor Filling date: 12 Sep 2025 Issue date: 4 Aug 2020 |
Application | Utility: HUMAN LAMBDA LIGHT CHAIN MICE Filling date: 12 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: Method of Characterization of Visible and/or Sub-Visible Particles in Biologics Filling date: 12 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: PROTEIN A CHROMATOGRAPHY - ELECTROSPRAY IONIZATION MASS SPECTROMETER Filling date: 12 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: Quantitation and Identification of Dimers In Co-Formulations Filling date: 12 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: ONLINE CHROMATOGRAPHY AND ELECTROSPRAY IONIZATION MASS SPECTROMETER Filling date: 12 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: BISPECIFIC ANTI-CD28 X ANTI-CD22 ANTIBODIES AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS OF USE THEREOF Filling date: 12 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: Treatment Of Ophthalmic Conditions With Angiopoietin-Like 7 (ANGPTL7) Inhibitors Filling date: 12 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: RODENT MODEL OF MOOD DISORDERS Filling date: 12 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: GPR156 Variants And Uses Thereof Filling date: 12 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: Rodents With Conditional ACVR1 Mutant Alleles Filling date: 12 Sep 2025 Issue date: 23 Jul 2020 |
Grant | Utility: System and method for characterizing protein dimerization Filling date: 12 Sep 2025 Issue date: 21 Jul 2020 |
Application | Utility: METHODS FOR IDENTIFYING FREE THIOLS IN PROTEINS Filling date: 12 Sep 2025 Issue date: 16 Jul 2020 |
Application | Utility: METHODS FOR CHARACTERIZING DISULFIDE BONDS Filling date: 12 Sep 2025 Issue date: 16 Jul 2020 |
Application | Utility: METHOD AND SYSTEM OF IDENTIFYING AND QUANTIFYING ANTIBODY FRAGMENTATION Filling date: 12 Sep 2025 Issue date: 16 Jul 2020 |
Application | Utility: HUMANIZED LIGHT CHAIN MICE Filling date: 12 Sep 2025 Issue date: 16 Jul 2020 |
Application | Utility: HUMANIZED LIGHT CHAIN MICE Filling date: 12 Sep 2025 Issue date: 16 Jul 2020 |
Grant | Utility: Methods and compositions for the targeted modification of a mouse ES cell genome Filling date: 12 Sep 2025 Issue date: 14 Jul 2020 |
Grant | Utility: Steroids and protein-conjugates thereof Filling date: 12 Sep 2025 Issue date: 14 Jul 2020 |
Application | Utility: METHODS FOR TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (heFH) WITH AN ANTI-PCSK9 ANTIBODY Filling date: 12 Sep 2025 Issue date: 9 Jul 2020 |
Application | Utility: DELIVERY OF A GENE-EDITING SYSTEM WITH A SINGLE RETROVIRAL PARTICLE AND METHODS OF GENERATION AND USE Filling date: 12 Sep 2025 Issue date: 9 Jul 2020 |
Showing 400 to 450 of 704 patents.